Roivant Sciences ROIV
NASDAQ ROIV
$35.72 +0.22 (+0.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Income from Discontinued Operations (2023 - 2024)

Updated

Roivant Sciences' Income from Discontinued Operations was $373.19 million in FY2025 (year ended Mar 31, 2025), compared with -$315.15 million in FY2024.

Analysis

Roivant Sciences (ROIV) Income from Discontinued Operations (2023 - 2024) Analysis & Trends

  • Per Business Quant data, Income from Discontinued Operations in earlier fiscal years was -$315.15 million in FY2024 and -$226.39 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Roivant Sciences 25.81 Bn 26.50 Bn 1.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 327.02 Mn
Sep 30, 2024 -43.08 Mn
Jun 30, 2024 89.09 Mn
Mar 31, 2024 -87.54 Mn
Dec 31, 2023 -58.52 Mn
Sep 30, 2023 -86.48 Mn
API Access

Roivant Sciences Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=ROIV&period=max&api_key=YOUR_API_KEY